Market capitalization | $1.72b |
Enterprise Value | $3.43b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 90.30 |
EV/Sales (TTM) EV/Sales | 2.19 |
P/S ratio (TTM) P/S ratio | 1.10 |
P/B ratio (TTM) P/B ratio | 1.13 |
Revenue growth (TTM) Revenue growth | 1.45% |
Revenue (TTM) Revenue | $1.56b |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
13 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:
13 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:
Sep '24 |
+/-
%
|
||
Revenue | 1,565 1,565 |
1%
1%
|
|
Gross Profit | 908 908 |
3%
3%
|
|
EBITDA | 279 279 |
21%
21%
|
EBIT (Operating Income) EBIT | 145 145 |
37%
37%
|
Net Profit | -6.54 -6.54 |
106%
106%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Head office | United States |
CEO | Jan Witte |
Employees | 5,329 |
Founded | 1989 |
Website | www.integralife.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.